Ligand assay technology in drugs of abuse screening point of care devices

Journal of Clinical Ligand Assay

Volumn 25, Issue 4, 2002, Pages 342-347

  Phillips, Jane Ellen ^a,b,c   Ambrose, Theresa M ^b   Hammett Stabler, Catherine ^c  

^a UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^b Roche Diagnostics Corporation   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Drugs of abuse; Immunoassay; Negative indicating reaction; Point of care; Positive indicating reaction

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; COCAINE; EPHEDRINE; LIGAND; MORPHINE; OPIATE; PHENCYCLIDINE; TETRAHYDROCANNABINOLIC ACID;

DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DRUG ABUSE; DRUG SCREENING; POINT OF CARE TEST; REVIEW; SCREENING; URINALYSIS; WORKPLACE;

DOA;

EID: 0038113239     PISSN: 10811672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Goldberg L, Elliot D, MacKinnon D, et al.: Drug testing athletes to prevent substance abuse: background and pilot study results of the SATURN (student athlete testing using random notification) study. Journal of Adolescent Health 2003;32(1):16-25.
2. Torre RDL, Domingo-Salvany A, Badia R, et al.: Clinical evaluation of the Triage® analytical device for drugs-of-abuse testing. Clin Chem 1996;42(9):1433-1438.
3. Wu AHB: Near-patient and point-of-care testing for alcohol and drugs of abuse. Ther Drug Monit Toxicol 1995;16(9):227-236.
4. Valentine JL, Komoroski EM: Use of a visual panel detection method for drugs of abuse: clinical and laboratory experience with children and adolescents. Pediatr Pharmacol Ther 1995;126(1):135-140.
5. Wu AHB, Wong SS, Johnson KG, et al.: Evaluation of the Triage® system for emergency drugs-of-abuse testing in urine. J Anal Toxicol 1993;17:241-245.
6. Ferrara SD, Tedeschi L, Frison G et al.: Drugs-of-abuse testing in urine: Statistical approach and experimental comparison of immunochemical and chromatographic techniques. J Anal Toxicol 1994;18:278-291.
7. Jenkins AJ, Mills LC, Darwin WD, Huestis MA, Cone EJ: Validity testing of the EZ-SCREENTM cannabinoid test. J Anal Toxicol 1993;17:292-298.
8. Buechler KF, Moi S, Noar B, et al.: Simultaneous detection of seven drugs of abuse by the Triage® panel for drugs of abuse. Clin Chem 1992;38(9):1678-1684.
9. Ros JJW, Pelders MG, Egberts ACG: Performance of Abusign™ Drugs of abuse slide tests with particular emphasis on cencentrations near the cutoff: Comparison with FPIA-ADx® and confirmation of results with GC-MS. J Anal Toxicol 1998;22:40-44.
10. Kranzler HR, Stone J, McLauglin L: Evaluation of a point-of-care testing product for drugs of abuse: testing site is a key variable. Drug Alcohol Depend 1995;40:55-62.
11. Kadehjian LJ: Performance of five non-instrumented urine drug-testing devices with challenging near-cutoff specimens. J Anal Toxicol 2001; Nov-Dec 25(8):670-679.
12. Farrell LJ: Abuscreen ONTRAK® tests for drugs of abuse, in Goldberg, BA and Jenkins AJ, (eds). On-Site Drug Testing, Totowa, NJ, Humana Press, 2002, pg 153.
13. Triage® Drugs of Abuse Panel Plus TCA, product insert, Biosite® Incorporated.
14. Cody, JT: Sample adulteration and on-site drug tests, in Goldberg, BA and Jenkins AJ, (eds). On-Site Drug Testing, Totowa, NJ, Humana Press, 2002, pg 253.
15. Cody JT, Valtier S: Effects of Stealth™ adulterant on immunoassay testing for drugs of abuse. J Anal Toxicol 2001;Sept 25(6): 466-470.
16. Cody JT, Valtier S, Kuhlman J: Analysis of morphine and codeine in samples adulterated with Stealth™. J Anal Toxicol 2001;Oct 25(7):572-575.
17. U.S. Department of Transporation. Procedures for transportation workplace drug and alcohol testing programs: proposed rules. Fed Reg 1999;64:69076-69136.
18. Hicks JM, Haeckel R, Price CP, Lewandrowski K, Wu AH: Recommendations and opinions for the use of point-of-care testing for hospitals and primary care: summary of a 1999 symposium. Clin Chim Acta 2001;303(1-2):1-17.
19. Schramm W, Smith RH, Craig PA, Kidwell DA: Drugs of abuse in saliva: A review. J Anal Toxicol 1992;16:1-9.
20. Schramm W, Craig PA, Smith RH, Berger GE: Cocaine and benzoylecgonine in saliva, serum and urine. Clin Chem 1993; 39(3):481-487.
21. George S, Braithwaite RA: Use of on-site testing for drugs of abuse (review). Clin Chem 2002;48(10):1639-1646.